February 2019

February 2019

Welcome to the February issue of The Ophthalmologist! You’ll find the latest research in Upfront – our news segment – plus opinion pieces from some of ophthalmology’s brightest minds in In My View. This month, Jeffrey O’Callaghan looks at the potential gene medications targeting conventional aqueous outflow, while Tim Schultz explains why FLACS is the way forward for Fuchs dystrophy patients in need of cataract extraction. In our feature, Off the Beaten Track, we shine a light on international outreach efforts, asking six ordinary ophthalmologists how they promote positive, sustainable change – at home and overseas. In Practice sees Priya Narang and Amar Agarwal give their thoughts on single-pass four throw (SFT) pinhole pupilloplasty, while Mark Milner argues that when it comes to treating ocular surface disease, cryopreservation holds the key healing characteristics of amniotic membrane. In NextGen, Harvard chemist, Eugene Serebryany, tells us how he uncovered the complex mechanism behind cataract formation, while Christos Bergeles and Lyndon da Cruz explain how robotic hands will bring new precision to retinal surgery. Finally, we sit down with Rainer Kirchhübel, CEO of OCULUS Optikgeräte GmbH.